{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:49:52Z","timestamp":1791726592898,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"ministero della salute","doi-asserted-by":"publisher","award":["Ricerca Corrente"],"award-info":[{"award-number":["Ricerca Corrente"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is a high incidence of cardiovascular disease in diabetes. Weight variability has been reported as independent risk factor for cardiovascular disease in the general population and preliminarily also in people with type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using data from the Swedish National Diabetes Register the possible link between visit-to-visit body weight variability and the risk of cardiovascular complications among people with type 2 diabetes and without prevalent cardiovascular diseases at baseline has been evaluated. Overall, 100,576 people with type 2 diabetes, with at least five measurements of body weight taken over three consecutive years, were included. Variability was expressed as quartiles of the standard deviation of the measures during the three years. The primary composite outcome included non-fatal myocardial infarction, non-fatal stroke, and all-cause mortality and was assessed during five years following the first 3 years of exposure to weight variability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After adjusting for known cardiovascular risk factors, the risk of the primary composite outcome significantly increased with increasing body weight variability [upper quartile HR\u2009=\u20091.45; 95% confidence interval 1.39\u20131.52]. Furthermore, elevated body weight variability was associated with almost all the other cardiovascular complications considered (non-fatal myocardial infarction, non-fatal stroke, all-cause mortality, peripheral arterial disease, peripheral vascular angioplasty, hospitalization for heart failure, foot ulcer, and all-cause mortality).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>High body weight variability predicts the development of cardiovascular complications in type 2 diabetes. These data suggest that any strategy to reduce the body weight in these subjects should be aimed at maintaining the reduction in the long-term, avoiding oscillations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-021-01360-0","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T20:04:11Z","timestamp":1630008251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Variability in body weight and the risk of cardiovascular complications in type 2 diabetes: results from the Swedish National Diabetes Register"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8122-3203","authenticated-orcid":false,"given":"Antonio","family":"Ceriello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lucisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Prattichizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Eliasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Franz\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Marie","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Nicolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"key":"1360_CR1","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1056\/NEJM199106273242602","volume":"324","author":"L Lissner","year":"1991","unstructured":"Lissner L, Odell PM, D\u2019Agostino RB, et al. Variability of body weight and health outcomes in the Framingham population. N Engl J Med. 1991;324:1839\u201344.","journal-title":"N Engl J Med"},{"key":"1360_CR2","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.1038\/s41598-019-46037-7","volume":"9","author":"D Choi","year":"2019","unstructured":"Choi D, Choi S, Park SM. Impact of weight variability on mortality among Korean men and women: a population based study. Sci Rep. 2019;9:9543.","journal-title":"Sci Rep"},{"key":"1360_CR3","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.118.034978","volume":"138","author":"MK Kim","year":"2018","unstructured":"Kim MK, Han K, Park YM, Sang H. Associations of variability in blood pressure, glucose and cholesterol concentrations, and body mass index with mortality and cardiovascular outcomes in the general population. Circulation. 2018;138:2627\u201337.","journal-title":"Circulation"},{"key":"1360_CR4","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1056\/NEJMoa1606148","volume":"376","author":"S Bangalore","year":"2017","unstructured":"Bangalore S, Fayyad R, Laskey R, DeMicco DA, Messerli FH, Waters DD. Body-weight fluctuations and outcomes in coronary disease. N Engl J Med. 2017;376:1332\u201340.","journal-title":"N Engl J Med"},{"key":"1360_CR5","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","volume":"376","author":"A Rawshani","year":"2017","unstructured":"Rawshani A, Rawshani A, Franz\u00e9n S, et al. Mortality and cardiovascular disease in Type 1 and Type 2 Diabetes. N Engl J Med. 2017;376:1407\u201318.","journal-title":"N Engl J Med"},{"key":"1360_CR6","doi-asserted-by":"crossref","first-page":"e004724","DOI":"10.1161\/CIRCOUTCOMES.118.004724","volume":"11","author":"S Bangalore","year":"2018","unstructured":"Bangalore S, Fayyad R, DeMicco DA, Colhoun HM, Waters DD. Body weight variability and cardiovascular outcomes in patients with type 2 diabetes mellitus. Circ Cardiovasc Qual Outcomes. 2018;11:e004724.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"1360_CR7","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.amjcard.2018.11.016","volume":"123","author":"P Yeboah","year":"2019","unstructured":"Yeboah P, Hsu FC, Bertoni AG, Yeboah J. Body Mass Index, change in weight, body weight variability and outcomes in type 2 diabetes mellitus (from the ACCORD Trial). Am J Cardiol. 2019;123:576\u201381.","journal-title":"Am J Cardiol"},{"issue":"1","key":"1360_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijcard.2011.09.039","volume":"162","author":"W Doehner","year":"2012","unstructured":"Doehner W, Erdmann E, Cairns R, Clark AL, Dormandy JA, Ferrannini E, Anker SD. Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int J Cardiol. 2012;162(1):20\u20136.","journal-title":"Int J Cardiol"},{"issue":"9","key":"1360_CR9","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.2337\/dc19-2552","volume":"43","author":"GE Nam","year":"2020","unstructured":"Nam GE, Kim W, Han K, et al. Body weight variability and the risk of cardiovascular outcomes and mortality in patients with type 2 diabetes: a nationwide cohort study. Diabetes Care. 2020;43(9):2234\u201341.","journal-title":"Diabetes Care"},{"key":"1360_CR10","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1056\/NEJMoa1504347","volume":"373","author":"M Tancredi","year":"2015","unstructured":"Tancredi M, Rosengren A, Svensson AM, et al. Excess mortality among persons with Type 2 Diabetes. N Engl J Med. 2015;373:1720\u201332.","journal-title":"N Engl J Med"},{"issue":"1","key":"1360_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12933-021-01289-4","volume":"20","author":"A Ceriello","year":"2021","unstructured":"Ceriello A, Prattichizzo F. Variability of risk factors and diabetes complications. Cardiovasc Diabetol. 2021;20(1):101.","journal-title":"Cardiovasc Diabetol"},{"key":"1360_CR12","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/dmrr.897","volume":"24","author":"G Zoppini","year":"2008","unstructured":"Zoppini G, Verlato G, Targher G, Bonora E, Trombetta M, Muggeo M. Variability of body weight, pulse pressure and glycaemia strongly predict total mortality in elderly type 2 diabetic patients. The Verona Diabetes Study. Diabetes Metab Res Rev. 2008;24:624\u20138.","journal-title":"Diabetes Metab Res Rev"},{"key":"1360_CR13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.70252\/ASAQ8961","volume":"2","author":"K Strohacker","year":"2009","unstructured":"Strohacker K, Carpenter KC, McFarlin BK. Consequences of weight cycling: an increase in disease risk? Int J Exerc Sci. 2009;2:191\u2013201.","journal-title":"Int J Exerc Sci"},{"key":"1360_CR14","doi-asserted-by":"publisher","first-page":"100045","DOI":"10.1016\/j.ijchy.2020.100045","volume":"6","author":"J Turicchi","year":"2020","unstructured":"Turicchi J, O\u2019Driscoll R, Horgan G, et al. Body weight variability is not associated with changes in risk factors for cardiometabolic disease. Int J Cardiol Hypertens. 2020;6:100045.","journal-title":"Int J Cardiol Hypertens."},{"key":"1360_CR15","first-page":"98","volume":"2","author":"K Strohacker","year":"2010","unstructured":"Strohacker K, McFarlin BK. Influence of obesity, physical inactivity, and weight cycling on chronic inflammation. Front Biosci (Elite Ed). 2010;2:98\u2013104.","journal-title":"Front Biosci (Elite Ed)"},{"key":"1360_CR16","first-page":"2052","volume":"16","author":"X Li","year":"2018","unstructured":"Li X, Jiang L, Yang M, Wu YW, Sun JZ. Impact of weight cycling on CTRP3 expression, adipose tissue inflammation and insulin sensitivity in C57BL\/6J mice. Exp Ther Med. 2018;16:2052\u20139.","journal-title":"Exp Ther Med"},{"key":"1360_CR17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/sj.ijo.0802221","volume":"27","author":"H Yatsuya","year":"2003","unstructured":"Yatsuya H, Tamakoshi K, Yoshida T, et al. Association between weight fluctuation and fasting insulin concentration in Japanese men. Int J Obes Relat Metab Disord. 2003;27:478\u201383.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"1360_CR18","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1161\/01.ATV.0000122852.22604.78","volume":"24","author":"A Ceriello","year":"2004","unstructured":"Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004;24:816\u201323.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"1360_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3389\/fendo.2019.00451","volume":"4","author":"P de Candia","year":"2019","unstructured":"de Candia P, Prattichizzo F, Garavelli S, et al. Type 2 diabetes: how much of an autoimmune disease? Front Endocrinol (Lausanne). 2019;4(10):451.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"1360_CR20","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1111\/dom.14081","volume":"22","author":"F Prattichizzo","year":"2020","unstructured":"Prattichizzo F, Giuliani A, Sabbatinelli J, et al. Prevalence of residual inflammatory risk and associated clinical variables in patients with type 2 diabetes. Diabetes Obes Metab. 2020;22(9):1696\u2013700.","journal-title":"Diabetes Obes Metab"},{"issue":"2_suppl","key":"1360_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/2047487319878373","volume":"26","author":"L La Sala","year":"2019","unstructured":"La Sala L, Prattichizzo F, Ceriello A. The link between diabetes and atherosclerosis. Eur J Prev Cardiol. 2019;26(2_suppl):15\u201324.","journal-title":"Eur J Prev Cardiol"},{"key":"1360_CR22","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1038\/s41598-019-40107-6","volume":"9","author":"HV Sarin","year":"2019","unstructured":"Sarin HV, Lee JH, Jauhiainen M, et al. Substantial fat mass loss reduces low-grade inflammation and induces positive alteration in cardiometabolic factors in normal-weight individuals. Sci Rep. 2019;9:3450.","journal-title":"Sci Rep"},{"key":"1360_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cels.2017.12.013","volume":"6","author":"BD Piening","year":"2018","unstructured":"Piening BD, Zhou W, Contrepois K, et al. Integrative personal omics profiles during periods of weight gain and loss. Cell Syst. 2018;6:157-70.e8.","journal-title":"Cell Syst"},{"issue":"Supplement 1","key":"1360_CR24","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.2337\/dc21-S008","volume":"44","author":"American Diabetes Association","year":"2021","unstructured":"American Diabetes Association. Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes\u20142021. Diabetes Care. 2021;44(Supplement 1):S100\u201310.","journal-title":"Diabetes Care"},{"key":"1360_CR25","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2337\/dc10-2415","volume":"34","author":"RR Wing","year":"2011","unstructured":"Wing RR, Lang W, Wadden TA, et al. Look AHEAD Research Group. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34:1481\u20136.","journal-title":"Diabetes Care"},{"key":"1360_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa1212914","volume":"369","author":"RR Wing","year":"2013","unstructured":"Wing RR, Bolin P, Brancati FL, et al. Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145\u201354.","journal-title":"N Engl J Med"},{"key":"1360_CR27","doi-asserted-by":"crossref","unstructured":"Look AHEAD Research Group; Gregg E,\u00a0Jakicic J, Blackburn G, et al. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2016;4:913\u201321.","DOI":"10.1016\/S2213-8587(16)30162-0"},{"issue":"Suppl 1","key":"1360_CR28","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1079\/BJN20041135","volume":"92","author":"AJ Hill","year":"2004","unstructured":"Hill AJ. Does dieting make you fat? Br J Nutr. 2004;92(Suppl 1):S15\u20138.","journal-title":"Br J Nutr"},{"issue":"2_suppl","key":"1360_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/2047487319880040","volume":"26","author":"F Prattichizzo","year":"2019","unstructured":"Prattichizzo F, La Sala L, Ryd\u00e9n L, et al. Glucose-lowering therapies in patients with type 2 diabetes and cardiovascular diseases. Eur J Prev Cardiol. 2019;26(2_suppl):73\u201380.","journal-title":"Eur J Prev Cardiol"},{"issue":"14","key":"1360_CR30","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1056\/NEJMoa2007123","volume":"384","author":"DJA Jenkins","year":"2021","unstructured":"Jenkins DJA, Dehghan M, Mente A, et al. Glycemic index, glycemic load, and cardiovascular disease and mortality. N Engl J Med. 2021;384(14):1312\u201322.","journal-title":"N Engl J Med"},{"key":"1360_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/2333721418786565","author":"M Rennemark","year":"2018","unstructured":"Rennemark M, Jogr\u00e9us C, Elmst\u00e5hl S, Welmer A, Wimo A, Sanmartin-Berglund J. Relationships between frequency of moderate physical activity and longevity: an 11-year follow-up study. Gerontol Geriatr Med. 2018. https:\/\/doi.org\/10.1177\/2333721418786565.","journal-title":"Gerontol Geriatr Med"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-021-01360-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-021-01360-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-021-01360-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T04:39:20Z","timestamp":1725683960000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-021-01360-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1360"],"URL":"https:\/\/doi.org\/10.1186\/s12933-021-01360-0","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,26]]},"assertion":[{"value":"7 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients have consented to being reported in the Swedish National Diabetes Register, while no individual consent is required to be included in this study according to Swedish law. The regional ethical review board approved this study protocol.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors do not have competing interests to declare for this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"173"}}